Main menu

Spanish-language webinar: Integrating Nanopore Sequencing Into Clinical Research - Case Studies in Pathogen, Cancer and Genomics Analysis


Long-read sequencing provides advantages over short reads for a multitude of applications including characterising pathogens, analysing cancer genomic alterations and accurately detecting structural variants in the human genome.

In this webinar, Dr. Alfredo Hidalgo Miranda demonstrates the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research. He showcases the use of the Oxford Nanopore sequencing platform to sequence SARS-CoV-2 and Mycobacterium tuberculosis to monitor viral evolution and drug resistance. Dr. Hidalgo Miranda also highlights the transcriptomic analysis, characterisation of chromosomal translocations and the identification of mutations with diagnostic potential in lymphoblastic leukemia samples.

Authors: Alfredo Hidalgo Miranda, PhD Principal Investigator at Instituto Nacional de Medicina Genomica Dr. Alfredo Hidalgo Miranda is a Biologist and a PhD in Biomedical research. His current work at the Cancer Genomics laboratory of the Mexican National Institute of Genomic Medicine, is focused on the analysis of genomic and transcriptomic alterations in human tumours, particularly breast cancer. He has recently incorporated long-read sequencing analysis to improve the characterisation of genomic diversity in the Mexican population and the analysis of cancer and rare diseases.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag